NCT02893904

Brief Summary

A cerebral pharmacodynamic feedback may help the anesthesiologist to adjust anesthetics administration. The BIS, which provides a single number resulting from an algorithm calculated from cortical EEG parameters, may play this role.Moreover, halogenated agents and propofol may have different EEG effects, which might interfere on measured BIS values. The aim of this prospective randomized study was to compare, in steady state conditions, the EEG profiles in children anesthetized with sevoflurane (S) or propofol (P) : for both anesthetics, the BIS-concentration relationship and raw EEG were analysed at different levels of general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2005

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2005

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2006

Completed
9.1 years until next milestone

First Submitted

Initial submission to the registry

January 21, 2016

Completed
8 months until next milestone

First Posted

Study publicly available on registry

September 9, 2016

Completed
Last Updated

July 9, 2020

Status Verified

July 1, 2020

Enrollment Period

1.9 years

First QC Date

January 21, 2016

Last Update Submit

July 7, 2020

Conditions

Keywords

PropofolSevofluraneBispectral IndexChildrenElectroencephalographic signs

Outcome Measures

Primary Outcomes (1)

  • Bispectral profiles

    For each patient, before surgery and according to the constraints of operating schedule, one or two 10 min steady state periods were performed at a fixed FeS randomized between 1, 2, 3, 4 and 5 % of Sevoflurane in the Sevoflurane group or at a fixed Ct P randomized between 2, 3, 4, 5 and 6 mcg/ml in the propofol group.

    The average value of BIS is calculated on the last minute of each ten minutes steady state period .

Secondary Outcomes (2)

  • Incidence of epileptiform EEG signs

    Last minute of each ten minutes steady state period

  • Spectral analysis of EEG signal

    Last minute of each ten minutes steady state period

Study Arms (2)

Propofol

EXPERIMENTAL

General anesthesia by TCI Propofol and Remifentanil guided by BIS EEG monitoring intervention

Device: EEG monitoringDevice: Target Controlled Infusion

Sevoflurane

EXPERIMENTAL

General anesthesia by Sevoflurane and Remifentanil guided by BIS EEG monitoring intervention

Device: EEG monitoringDevice: Target Controlled Infusion

Interventions

Steady state concentrations periods of Propofol for EEG data analyzes. Remifentanil was administrated at constant rate in all patients.

PropofolSevoflurane

Steady state effect site concentrations of remifentanil administrated to all patients.

Also known as: TCI
PropofolSevoflurane

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • from five to eighteen year of age, ASA 1 or 2, scheduled for middle ear surgery

You may not qualify if:

  • obesity (body mass index \> percentile 97); history of cardiac, pulmonary, or renal disease; known neurological or neuromuscular disorders; preoperative administration of medications known to interfere with the central nervous system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Departement d'anesthesie Hopital Armand Trousseau

Paris, 75012, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pr Isabelle CONSTANT

Study Record Dates

First Submitted

January 21, 2016

First Posted

September 9, 2016

Study Start

January 1, 2005

Primary Completion

December 1, 2006

Study Completion

December 1, 2006

Last Updated

July 9, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations